Compound Detail
CHEMBL1444
LETROZOLE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1444 |
| Name | LETROZOLE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | HPJKCIUCZWXJDR-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
4
Targets
59
Activities
3
Assay Types
18
PK Parameters
20
Publications
7
Known Names
20
Indications
1
Mechanisms
Molecular Properties
285.3
MW (Da)
2.66
ALogP
5
HBA
0
HBD
78.3
PSA (Ų)
0.74
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1997 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cytochrome P450 19A1 inhibitor | INHIBITOR | Aromatase | ✓ | ✓ |
Indications
Breast Neoplasms Breast Neoplasms Breast Neoplasms Neoplasms Neoplasms Abortion, Spontaneous Azoospermia Carcinoma, Intraductal, Noninfiltrating Endometrial Neoplasms Endometrial Neoplasms Endometrial Neoplasms Follicular Cyst Hereditary Breast and Ovarian Cancer Syndrome Hypogonadism Infertility Menopause Neoplasm Metastasis Osteoporosis Ovarian Hyperstimulation Syndrome Ovarian Neoplasms
ATC Classification
L02BG04
letrozole
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ENDOCRINE THERAPY
Activity Summary
IC50 56 meas. best 9.15
Ki 2 meas. best 10.7
EC50 1 meas.
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Aromatase CHEMBL1978 | Ki | 10.7 | 9.68 | 0.0 | 2 |
| Aromatase CHEMBL1978 | IC50 | 9.15 | 8.1492 | 0.7 | 48 |
| MCF7 CHEMBL387 | IC50 | 8.15 | 6.326 | 7.0 | 5 |
| Cytochrome P450 11B2, mitochondrial CHEMBL2722 | IC50 | 5.85 | 5.85 | 1420.0 | 1 |
| Cytochrome P450 11B1, mitochondrial CHEMBL1908 | IC50 | 5.58 | 5.58 | 2620.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 0.57 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.57 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.57 | mL.min-1.kg-1 | Homo sapiens |
| CL | 3.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 0.58 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 115.0 | nM | Homo sapiens |
| Excretion | 3.9 | % | Homo sapiens |
| F | 99.9 | % | Homo sapiens |
| F | 99.9 | % | Homo sapiens |
| Fu | 0.41 | - | Homo sapiens |
| Fu | 0.41 | - | Homo sapiens |
| MRT | 59.0 | hr | Homo sapiens |
| T1/2 | 45.0 | hr | Homo sapiens |
| T1/2 | 45.0 | hr | Homo sapiens |
| Tmax | 1.0 | hr | Homo sapiens |
| Vd | 1.9 | L.kg-1 | Homo sapiens |
| Vd | 1.87 | L.kg-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 270 |
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| 31158845 | 10.1038/s41586-019-1291-3 | ADMET | 69 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 38809993 | 10.1021/acs.jmedchem.4c00196 | MCF7 | 6 |
| - | 10.1007/s00044-012-0133-8 | ADMET | 5 |
| 20102168 | 10.1021/np9004695 | Aromatase | 4 |
| 17580845 | 10.1021/jm061462b | Rattus norvegicus | 4 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 17287126 | 10.1016/j.bmc.2007.01.031 | Aromatase | 4 |
| 24025069 | 10.1021/jm400377z | Aromatase | 3 |
| 20148564 | 10.1021/jm901705h | Rattus norvegicus | 3 |
| 24345481 | 10.1016/j.bmc.2013.11.045 | MCF7 | 2 |
| 22951074 | 10.1021/jm300930n | Aromatase | 2 |
| 19445515 | 10.1021/jm900403j | Homo sapiens | 2 |
| - | 10.1039/C2MD20072D | Cytochrome P450 11B1, mitochondrial | 2 |
| 24025069 | 10.1021/jm400377z | NON-PROTEIN TARGET | 2 |
| 19072235 | 10.1021/jm800945c | Aromatase | 2 |
| 24025069 | 10.1021/jm400377z | HeLa | 2 |
Data from ChEMBL 36 via Core Engine